Consultorio de Investigación Clínica EMO SRL
Ciudad Autonoma De Buenos Aire, Buenos Air, Argentina
Medical office in Buenos Aires
Eduardo Acevedo 42, C1405 BUB, Buenos Aires
About Consultorio de Investigación Clínica EMO SRL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Pfizer
2
Clinical Trials at Consultorio de Investigación Clínica EMO SRL
During the past decade, Consultorio de Investigación Clínica EMO SRL conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
2022-03-08
2024-05-14
Active, not recruiting
986
A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
2022-08-11
2024-03-01
Recruiting
670
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
2022-08-12
2024-05-06
Active, not recruiting
692
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Consultorio de Investigación Clínica EMO SRL
According to Clinical.Site data, the most researched conditions in "Consultorio de Investigación Clínica EMO SRL" are
"Cardiovascular Disease" (2 trials), "Type 2 Diabetes" (2 trials), "Diabetes" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Consultorio de Investigación Clínica EMO SRL" in a lesser frequency.
Clinical Trials Intervention Types at Consultorio de Investigación Clínica EMO SRL
Most popular intervention types in "Consultorio de Investigación Clínica EMO SRL" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Insulin Efsitora Alfa" (3 trials), "Placebo" (3 trials), "Insulin Degludec" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Insulin Glargine (U100)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Consultorio de Investigación Clínica EMO SRL
The vast majority of trials in "Consultorio de Investigación Clínica EMO SRL" are
6 trials for "All" genders.
Clinical Trials Status at Consultorio de Investigación Clínica EMO SRL
Currently, there are NaN active trials in "Consultorio de Investigación Clínica EMO SRL".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Consultorio de Investigación Clínica EMO SRL,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Consultorio de Investigación Clínica EMO SRL, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".